[1]陈 娟.丁苯酞对急性脑梗死患者神经功能及血清S100B、同型半胱氨酸和血管生成素-1水平的影响[J].新乡医学院学报,2018,35(6):498-501.[doi:10.7683/xxyxyxb.2018.06.012]
 CHEN Juan.Effect of butylphthalide on the neurological function and the levels of serum S100B,homocysteine,angiopoietin-1 in patients with acute cerebral infarction[J].Journal of Xinxiang Medical University,2018,35(6):498-501.[doi:10.7683/xxyxyxb.2018.06.012]
点击复制

丁苯酞对急性脑梗死患者神经功能及血清S100B、同型半胱氨酸和血管生成素-1水平的影响
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年6
页码:
498-501
栏目:
临床研究
出版日期:
2018-06-05

文章信息/Info

Title:
Effect of butylphthalide on the neurological function and the levels of serum S100B,homocysteine,angiopoietin-1 in patients with acute cerebral infarction
作者:
陈 娟
(河南省荣军医院神经内科,河南 新乡 453000)
Author(s):
CHEN Juan
(Department of Neurology,Henan Rongjun Hospital,Xinxiang 453000,Henan Province,China)
关键词:
丁苯酞急性脑梗死同型半胱氨酸S100B血管生成素-1神经功能
Keywords:
butylphthalideacute cerebral infarctionhomocysteineS100Bangiogenin-1neurological function
分类号:
R743.33
DOI:
10.7683/xxyxyxb.2018.06.012
文献标志码:
A
摘要:
目的 探讨丁苯酞对急性脑梗死(ACI)患者的神经功能及血清S100B、同型半胱氨酸(Hcy)及血管生成素-1(ANG-1)水平的影响。方法 选择2016年1月至2017年9月河南省荣军医院收治的ACI患者84例,根据治疗方法分为观察组和对照组,每组42例。2组患者均给予抗血栓、控制血糖和血压、营养支持、预防感染等常规治疗措施,观察组患者在常规治疗基础上给予丁苯酞注射液100 mL,静脉滴注,每日2次,连续治疗2周。分别于治疗前后应用美国国立卫生研究院卒中量表(NIHSS)对2组患者的神经功能缺损进行评分,应用简易精神状态评价量表(MMSE)对2组患者的智力状态及认知功能进行评分,采用酶联免疫吸附试验检测血清S100B、ANG-1水平,采用AU480全自动生物化学分析仪检测Hcy水平;治疗2周后进行疗效评价,并观察患者不良反应发生情况。结果 2组患者治疗前NIHSS、MMSE评分比较差异均无统计学意义(P>0.05);2组患者治疗后NIHSS评分显著低于治疗前,MMSE评分显著高于治疗前(P<0.05);治疗后观察组患者NIHSS评分显著低于对照组,MMSE评分显著高于对照组(P<0.05)。2组患者治疗前血清S100B、Hcy及ANG-1水平比较差异均无统计学意义(P>0.05);2组患者治疗后血清S100B、Hcy水平显著低于治疗前,ANG-1水平显著高于治疗前(P<0.05);治疗后观察组患者血清S100B、Hcy水平显著低于对照组,ANG-1水平显著高于对照组(P<0.05)。观察组和对照组患者治疗总有效率分别为90.48%(38/42)、71.43%(30/42),观察组患者治疗总有效率显著高于对照组(χ2=4.659,P<0.05)。观察组和对照组患者不良反应发生率分别为11.90%(5/42)、9.52%(4/42),2组患者不良反应发生率比较差异无统计学意义(χ2=0.092,P>0.05)。结论 丁苯酞可以有效调节ACI患者血清S100B、Hcy和ANG-1水平,改善患者的神经功能。
Abstract:
Objective To investigate the effect of butylphthalide on the neurological function and the levels of (S-100B),homocysteine(Hcy),angiopoietin-1(ANG-1) in patients with acute cerebral infarction(ACI).Methods A total of 84 patients with ACI were selected from January 2016 to September 2017 in Henan Rongjun Hospital.The patients were divided into observation group and control group according to the treatment method,with 42 cases in each group.The patients in the two groups were treated with antithrombosis,blood sugar and blood pressure control,nutritional support,infection prevention and other conventional treatment measures.On the basis of routine treatment,the patients in the observation group were treated with butylphthalide injection 100 mL by intravenously guttae,twice a day for two weeks.The neurologic impairment of the patients in the two groups was assessed by the National Institutes of Health Stroke Scale(NIHSS) before and after treatment.The mental state and cognitive function of the patients in the two groups were scored by the mini-mental state examination(MMSE).The levels of serum S100B and ANG-1 were detected by Enzyme-linked immunosorbent assay.The level of Hcy was detected by AU480 automatic biochemical analyzer.The curative effect was evaluated after two weeks of treatment,and the adverse reactions of the patients were observed.Results There was no significant difference in the scores of NIHSS and MMSE between the two groups before treatment(P>0.05).The NIHSS score after treatment was significantly lower than that before treatment,and the MMSE score was significantly higher than that before treatment in the two groups(P<0.05).The NIHSS score in the observation group was significantly lower than that in the control group,and the MMSE score was significantly higher than that in the control group after treatment(P<0.05).There was no significant difference in serum S100B,Hcy and ANG-1 levels between the two groups before treatment(P>0.05).The levels of serum S100B and Hcy after treatment were significantly lower than those before treatment,and the ANG-1 level was significantly higher than that before treatment in the tao groups(P<0.05).The levels of serum S100B and Hcy in the observation group were significantly lower than those in the control group,and the ANG-1 level was significantly higher than that in the control group after treatment(P<0.05).The total effective rate in the observation group and the control group was 90.48%(38/42) and 71.43%(30/42) respectively,the total effective rate in the observation group was significantly higher than that in the control group(χ2=4.659,P<0.05).The incidence of adverse reactions in the observation group and the control group was 11.90%(5/42) and 9.52%(4/42) respectively,there was no significant difference in the incidence of adverse reactions between the two groups(χ2=0.092,P>0.05).Conclusion Butylphthalide can effectively regulate the levels of serum S100B,Hcy and ANG- 1,and improve the neurological function of patients with ACI.

参考文献/References:

[1] 吴威.盐酸小檗碱联合阿托伐他汀治疗急性脑梗死的疗效及对 颈动脉粥样硬化斑块的影响[J].中国老年学杂志,2016,36(18):4459-4460.
[2] 杨飞云,孔令宇,杨亚勤,等.重组人促红细胞生成素治疗急性脑梗死疗效观察[J].新乡医学院学报,2017,34(10):912-915.
[3] 陈海恋,何超明,庞明武,等.丁苯酞治疗老年急性脑梗死的疗效及对细胞因子和神经功能的影响[J].中华老年心脑血管病杂志,2016,18(11):1173-1177.
[4] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153.
[5] 李洪标,何丽艳,容宇,等.血清脂蛋白相关磷脂酶A2水平与急性脑梗死临床类型的相关性[J].实用医学杂志,2016,32(23):3914-3917.
[6] 陆丽丽,刘丹,庞春燕,等.急性脑梗死患者体内血小板CD62P和sTLT-1的表达水平[J].中风与神经疾病杂志,2017,34(2):105-107.
[7] 项正兵,屈新辉,王万松,等.急性脑梗死患者内皮祖细胞动态变化及其对神经功能的影响[J].中国老年学杂志,2015,35(16):4520-4524.
[8] 刘鸣银,魏麓云.丁苯酞对神经系统保护作用研究进展[J].现代医药卫生,2014,30(2):212-215.
[9] 张翀,陈蕾,李婷婷.血管生成素-1对小鼠视网膜新生血管和血管内皮生长因子的抑制作用[J].眼科新进展,2015,35(1):31-34.
[10] 王开,王海军.血管生成素-1与急性期脑梗死病灶周围侧支循环建立的相关性探讨[J].当代医学,2017,23(28):17-20.
[11] 金越,张敏,鲍星星,等.S100B 蛋白和行为神经评分对早产儿脑白质损伤的诊断价值[J].中华实用儿科临床杂志,2015,30(14):1110-1112.
[12] 云永利,陈萍.S100B的研究进展[J].医学综述,2017,23(1):46-49.
[13] 马晓敏,刘丹.视网膜静脉阻塞患者血小板参数及同型半胱氨酸水平的临床分析[J].眼科新进展,2017,37(10):973-975.
[14] 孙佳鹏,肖慧捷,丁洁,等.高同型半胱氨酸血症与儿童慢性肾脏病的关系[J].中华实用儿科临床杂志,2017,32(11):852-855.
[15] 黄漓莉,于健,周素娴,等.同型半胱氨酸和视黄醇结合蛋白4与糖尿病视网膜病变的相关性研究[J].眼科新进展,2016,36(3):244-246.
[16] 郝美美,邓艳春.同型半胱氨酸与神经系统疾病关系的研究进展[J].临床神经病学杂志,2016,29(1):66-69.

相似文献/References:

[1]何茶叶,刘 平,焦新彩,等.灯盏花素治疗急性脑梗死30例疗效观察[J].新乡医学院学报,2001,18(06):425.
[2]高连英,罗开国.降纤酶治疗急性脑梗死50例[J].新乡医学院学报,2003,20(02):143.
[3]陈娟,姬明丽.急性脑梗死患者血糖水平与梗死范围及预后的关系 [J].新乡医学院学报,2006,23(03):000.
[4]张同喜,张改芹.银杏达莫注射液治疗急性脑梗死61 例临床观察[J].新乡医学院学报,2006,23(05):507.
[5]毛向莹.依达拉奉治疗急性脑梗死疗效观察[J].新乡医学院学报,2008,25(01):045.
[6]赵红领,杜秦川.早期进展性脑梗死患者血浆D-二聚体水平变化[J].新乡医学院学报,2010,27(03):278.
[7]韩晨鹏,韩庆伟,姚文杰,等.急性脑梗死患者血清白细胞介素-6 及白细胞介素-8 和肿瘤坏死因子-α水平变化及临床意义[J].新乡医学院学报,2012,29(08):621.
[8]李 慧.阿替普酶溶栓后联合丹参多酚酸治疗急性脑梗死的疗效及安全性[J].新乡医学院学报,2019,36(11):1048.[doi:10.7683/xxyxyxb.2019.11.010]
 LI Hui.Efficacy and safety of alteplase combined with danshen polyphenolic acid in treatment of patients with acute cerebral infarction[J].Journal of Xinxiang Medical University,2019,36(6):1048.[doi:10.7683/xxyxyxb.2019.11.010]
[9]魏 亮,张小峰,张军峰.阿替普酶治疗急性脑梗死疗效观察[J].新乡医学院学报,2019,36(6):533.[doi:10.7683/xxyxyxb.2019.06.008]
 WEI Liang,ZHANG Xiao-feng,ZHANG Jun-feng.Effect of alteplase on acute cerebral infarction[J].Journal of Xinxiang Medical University,2019,36(6):533.[doi:10.7683/xxyxyxb.2019.06.008]
[10]李春燕,韩听锋,岳 磊.巴曲酶对急性脑梗死患者神经功能及日常生活能力和血液流变学的影响[J].新乡医学院学报,2019,36(6):544.[doi:10.7683/xxyxyxb.2019.06.011]
 LI Chun-yan,HAN Ting-feng,YUE Lei.Effect of batroxobin on neurological function,ability of daily living and hemorheology in patients with acute cerebral infarction[J].Journal of Xinxiang Medical University,2019,36(6):544.[doi:10.7683/xxyxyxb.2019.06.011]
[11]徐国卫,杨亚红,常小敬,等.丁苯酞治疗大脑中动脉狭窄所致急性脑梗死疗效观察[J].新乡医学院学报,2020,37(5):481.[doi:10.7683/xxyxyxb.2020.05.019]
 XU Guowei,YANG Yahong,CHANG Xiaojing,et al.Clinical effect of butylphthalide for acute cerebral infarction caused by middle cerebral artery stenosis[J].Journal of Xinxiang Medical University,2020,37(6):481.[doi:10.7683/xxyxyxb.2020.05.019]
[12]黄丽娟,张艳蕉,赵 亮,等.丁苯酞氯化钠注射液治疗中青年急性脑梗死疗效观察[J].新乡医学院学报,2017,34(7):586.[doi:10.7683/xxyxyxb.2017.07.008]
 HUANG Li-juan,ZHANG Yan-jiao,ZHAO Liang,et al.Efficacy of butylphthalide and sodium chloride injection in the treatment of young and middle aged patients with acute cerebral infarction[J].Journal of Xinxiang Medical University,2017,34(6):586.[doi:10.7683/xxyxyxb.2017.07.008]

更新日期/Last Update: 2018-06-05